Exact Mass: 555.2303988000001
Exact Mass Matches: 555.2303988000001
Found 500 metabolites which its exact mass value is equals to given mass value 555.2303988000001,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Demethyldecarbamoylnovobiocin
A hydroxycoumarin that is novobiocin lacking the 3-O-carbamoyl and 4-O-methyl groups from the hexose ring.
Tiapamil
C26H37NO8S2 (555.1960482000001)
C78274 - Agent Affecting Cardiovascular System > C270 - Antihypertensive Agent > C333 - Calcium Channel Blocker D002317 - Cardiovascular Agents > D002121 - Calcium Channel Blockers D000077264 - Calcium-Regulating Hormones and Agents D049990 - Membrane Transport Modulators C93038 - Cation Channel Blocker
15-Demethylaclacinomycin T
An anthracycline obtained by hydrolysis of the methyl ester group of aclacinomycin T.
Enkephalin L
Enkephalin L is an opioid peptide. Opioid peptides are a group of neuropeptides which include enkephalins, endorphins and dynorphins. In addition to their central and peripheral antinociceptive function, opioids can modulate immune activity and cell proliferation. Enkephalins typically have a turnover rate measured in seconds to minutes, both in vivo and in vitro, and this stability is related to the age of the cell system under study. It is noteworthy that the residues most essential to enkephalin function are also either neurotransmitters themselves (glycine) or immediate precursors of L-Dopa, dopamine and norepinephrine (tyrosine and phenylalanine). The variable fifth amino acid leucine (leu5) or methionine (met5) has not yet been assigned any neurotransmitter candidacy. Again, this suggests that enkephalin is polyfunctional in that, in its intact state it elicits binding to the same sites in the brain as morphine and other opiates, and its degradation products have a potential for follow-up accessory functions by reacting as signaling entities themselves, or as the immediate precursors to inhibitory or metabotropic neurotransmitters. Enkephalins are present in macrophages infiltrating the dermal papillae in involved psoriatic skin and that the amount of enkephalin is significantly increased in involved psoriatic skin. Major enkephalin pathways in the brain involve the extrapyramidal system, including motor pathways controlled by the basal ganglia, the limbic system that governs emotional and behavioral control, and the hypothalamic-neuroendocrine axis. The apparent overlap of localization within the central nervous system of dopaminergic, glycinergic, and enkephalinergic pathways is speculated to be of neurophysiological significance, especially in light of the relatively short half-life of the enkephalins and the immediate precursor-product relationship between tyrosine and dopamine, and glycinergic signaling. Enkephalins are released into the bloodstream of mammals by the adrenal medulla. Once they are in the blood, these peptides undergo a fairly rapid hydrolysis by several plasma-contained enzymes. However, a fraction of the enkephalins present in the plasma are bound to the serum albumin, and the bound peptides are almost completely intact even after a long incubation in the presence of serum enzymes. (PMID: 9450624, 16802191, 4069309) [HMDB] Enkephalin L is an opioid peptide. Opioid peptides are a group of neuropeptides which include enkephalins, endorphins and dynorphins. In addition to their central and peripheral antinociceptive function, opioids can modulate immune activity and cell proliferation. Enkephalins typically have a turnover rate measured in seconds to minutes, both in vivo and in vitro, and this stability is related to the age of the cell system under study. It is noteworthy that the residues most essential to enkephalin function are also either neurotransmitters themselves (glycine) or immediate precursors of L-Dopa, dopamine and norepinephrine (tyrosine and phenylalanine). The variable fifth amino acid leucine (leu5) or methionine (met5) has not yet been assigned any neurotransmitter candidacy. Again, this suggests that enkephalin is polyfunctional in that, in its intact state it elicits binding to the same sites in the brain as morphine and other opiates, and its degradation products have a potential for follow-up accessory functions by reacting as signaling entities themselves, or as the immediate precursors to inhibitory or metabotropic neurotransmitters. Enkephalins are present in macrophages infiltrating the dermal papillae in involved psoriatic skin and that the amount of enkephalin is significantly increased in involved psoriatic skin. Major enkephalin pathways in the brain involve the extrapyramidal system, including motor pathways controlled by the basal ganglia, the limbic system that governs emotional and behavioral control, and the hypothalamic-neuroendocrine axis. The apparent overlap of localization within the central nervous system of dopaminergic, glycinergic, and enkephalinergic pathways is speculated to be of neurophysiological significance, especially in light of the relatively short half-life of the enkephalins and the immediate precursor-product relationship between tyrosine and dopamine, and glycinergic signaling. Enkephalins are released into the bloodstream of mammals by the adrenal medulla. Once they are in the blood, these peptides undergo a fairly rapid hydrolysis by several plasma-contained enzymes. However, a fraction of the enkephalins present in the plasma are bound to the serum albumin, and the bound peptides are almost completely intact even after a long incubation in the presence of serum enzymes. (PMID: 9450624, 16802191, 4069309). D018377 - Neurotransmitter Agents > D018847 - Opioid Peptides D018377 - Neurotransmitter Agents > D004745 - Enkephalins [Leu5]-Enkephalin is a pentapeptide with morphine like properties. [Leu5]-Enkephalin is a five amino acid endogenous peptide that acts as an agonist at opioid receptors. [Leu5]-Enkephalin is a pentapeptide with morphine like properties. [Leu5]-Enkephalin is a five amino acid endogenous peptide that acts as an agonist at opioid receptors. [Leu5]-Enkephalin is a pentapeptide with morphine like properties. [Leu5]-Enkephalin is a five amino acid endogenous peptide that acts as an agonist at opioid receptors.
Adomeglivant
C32H36F3NO4 (555.2596292000001)
N-[(5Z)-5-(2,6-Dioxo-1,3-dipropylpurin-8-ylidene)-1-methyl-2H-pyrazol-3-yl]-2-[4-(phenylmethoxy)phenyl]acetamide
Fiduxosin
Rociletinib
C27H28F3N7O3 (555.2205614000001)
L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents > L01E - Protein kinase inhibitors > L01EB - Epidermal growth factor receptor (egfr) tyrosine kinase inhibitors C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C163952 - EGFR-targeting Agent C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor
4-[2-Acetylamino-2-(1-biphenyl-4-ylmethyl-2-oxo-azepan-3-ylcarbamoyl)-ethyl]-2-formyl-benzoic acid
C32H33N3O6 (555.2369238000001)
Isoflavone base + 1O, 1MeO, O-Hex+C7H12NO
Annotation level-3
scutebarbatine F
A diterpene alkaloid of group of neo-clerodanes isolated from the whole plants of Scutellaria barbata and has been shown to exhibit neoplastic activity.
[6-{(1E,3E)-5-[(2S,3S,5R,6R)-5-{[(2Z,4S)-4-(acetyloxy)pent-2-enoyl]amino}-3,6-dimethyltetrahydro-2H-pyran-2-yl]-3-methylpenta-1,3-dien-1-yl}-4-(chloromethyl)-4-hydroxytetrahydro-2H-pyran-2-yl]acetic acid
C28H42ClNO8 (555.2598802000001)
(2S,3S,4R,5R)-3,4-dimethyl-2-hydroxyl-5-(4-hydroxyl-4,5-methylenedioxy-6,3,5-trimethoxylbiphenyl-2-yl)tetrahydrofuranyl-8-oxo-1-oxa-3-azaspiro[4.5]dec-2-enyl-2,8-ether|gymnothelignan A
2-amino-5-[(5-beta-D-glucopyranosyl-4-hydroxy-cyclopent-2-enylamino)-methyl]-7-beta-D-ribofuranosyl-3,7-dihydro-pyrrolo[2,3-d]pyrimidin-4-one
Glu Arg His Asp
YGGFL
D018377 - Neurotransmitter Agents > D018847 - Opioid Peptides D018377 - Neurotransmitter Agents > D004745 - Enkephalins
Cys Asp Arg Tyr
C22H33N7O8S (555.2111218000001)
Cys Asp Tyr Arg
C22H33N7O8S (555.2111218000001)
Cys Phe Met Arg
Cys Phe Arg Met
Cys Phe Thr Trp
C27H33N5O6S (555.2151438000001)
Cys Phe Trp Thr
C27H33N5O6S (555.2151438000001)
Cys Met Phe Arg
Cys Met Arg Phe
Cys Arg Asp Tyr
C22H33N7O8S (555.2111218000001)
Cys Arg Phe Met
Cys Arg Met Phe
Cys Arg Tyr Asp
C22H33N7O8S (555.2111218000001)
Cys Thr Phe Trp
C27H33N5O6S (555.2151438000001)
Cys Thr Trp Phe
C27H33N5O6S (555.2151438000001)
Cys Trp Phe Thr
C27H33N5O6S (555.2151438000001)
Cys Trp Thr Phe
C27H33N5O6S (555.2151438000001)
Cys Tyr Asp Arg
C22H33N7O8S (555.2111218000001)
Cys Tyr Arg Asp
C22H33N7O8S (555.2111218000001)
Asp Cys Arg Tyr
C22H33N7O8S (555.2111218000001)
Asp Cys Tyr Arg
C22H33N7O8S (555.2111218000001)
Asp Glu His Arg
Asp Glu Arg His
Asp Phe Phe Lys
Asp Phe Phe Gln
Asp Phe Lys Phe
Asp Phe Gln Phe
Asp His Glu Arg
Asp His Arg Glu
Asp His Val Trp
Asp His Trp Val
Asp Lys Phe Phe
Asp Lys Met Tyr
Asp Lys Tyr Met
Asp Met Lys Tyr
Asp Met Gln Tyr
Asp Met Tyr Lys
Asp Met Tyr Gln
Asp Gln Phe Phe
Asp Gln Met Tyr
Asp Gln Tyr Met
Asp Arg Cys Tyr
C22H33N7O8S (555.2111218000001)
Asp Arg Glu His
Asp Arg His Glu
Asp Arg Tyr Cys
C22H33N7O8S (555.2111218000001)
Asp Val His Trp
Asp Val Trp His
Asp Trp His Val
Asp Trp Val His
Asp Tyr Cys Arg
C22H33N7O8S (555.2111218000001)
Asp Tyr Lys Met
Asp Tyr Met Lys
Asp Tyr Met Gln
Asp Tyr Gln Met
Asp Tyr Arg Cys
C22H33N7O8S (555.2111218000001)
Glu Asp His Arg
Glu Asp Arg His
Glu Phe Phe Asn
Glu Phe Asn Phe
Glu His Asp Arg
Glu His Arg Asp
Glu Met Asn Tyr
Glu Met Tyr Asn
Glu Asn Phe Phe
Glu Asn Met Tyr
Glu Asn Tyr Met
Glu Arg Asp His
Glu Tyr Met Asn
Glu Tyr Asn Met
Phe Cys Met Arg
Phe Cys Arg Met
Phe Cys Thr Trp
C27H33N5O6S (555.2151438000001)
Phe Cys Trp Thr
C27H33N5O6S (555.2151438000001)
Phe Asp Phe Lys
Phe Asp Phe Gln
Phe Asp Lys Phe
Phe Asp Gln Phe
Phe Glu Phe Asn
Phe Glu Asn Phe
Phe Phe Asp Lys
Phe Phe Asp Gln
Phe Phe Glu Asn
Phe Phe Gly Trp
C31H33N5O5 (555.2481568000001)
Phe Phe Lys Asp
Phe Phe Asn Glu
Phe Phe Gln Asp
Phe Phe Trp Gly
C31H33N5O5 (555.2481568000001)
Phe Gly Phe Trp
C31H33N5O5 (555.2481568000001)
Phe Gly Trp Phe
C31H33N5O5 (555.2481568000001)
Phe Ile Asn Tyr
Phe Ile Tyr Asn
Phe Lys Asp Phe
Phe Lys Phe Asp
Phe Lys Met Met
Phe Leu Asn Tyr
Phe Leu Tyr Asn
Phe Met Cys Arg
Phe Met Lys Met
Phe Met Met Lys
Phe Met Met Gln
C24H37N5O6S2 (555.2185142000001)
Phe Met Gln Met
C24H37N5O6S2 (555.2185142000001)
Phe Met Arg Cys
Phe Asn Glu Phe
Phe Asn Phe Glu
Phe Asn Ile Tyr
Phe Asn Leu Tyr
Phe Asn Tyr Ile
Phe Asn Tyr Leu
Phe Gln Asp Phe
Phe Gln Phe Asp
Phe Gln Met Met
C24H37N5O6S2 (555.2185142000001)
Phe Gln Val Tyr
Phe Gln Tyr Val
Phe Arg Cys Met
Phe Arg Met Cys
Phe Thr Cys Trp
C27H33N5O6S (555.2151438000001)
Phe Thr Trp Cys
C27H33N5O6S (555.2151438000001)
Phe Val Gln Tyr
Phe Val Tyr Gln
Phe Trp Cys Thr
C27H33N5O6S (555.2151438000001)
Phe Trp Phe Gly
C31H33N5O5 (555.2481568000001)
Phe Trp Gly Phe
C31H33N5O5 (555.2481568000001)
Phe Trp Thr Cys
C27H33N5O6S (555.2151438000001)
Phe Tyr Ile Asn
Phe Tyr Leu Asn
Phe Tyr Asn Ile
Phe Tyr Asn Leu
Phe Tyr Gln Val
Phe Tyr Val Gln
Gly Phe Phe Trp
C31H33N5O5 (555.2481568000001)
Gly Phe Trp Phe
C31H33N5O5 (555.2481568000001)
Gly Met Trp Tyr
C27H33N5O6S (555.2151438000001)
Gly Met Tyr Trp
C27H33N5O6S (555.2151438000001)
Gly Trp Phe Phe
C31H33N5O5 (555.2481568000001)
Gly Trp Met Tyr
C27H33N5O6S (555.2151438000001)
Gly Trp Tyr Met
C27H33N5O6S (555.2151438000001)
Gly Tyr Met Trp
C27H33N5O6S (555.2151438000001)
Gly Tyr Trp Met
C27H33N5O6S (555.2151438000001)
His Asp Glu Arg
His Asp Arg Glu
His Asp Val Trp
His Asp Trp Val
His Glu Asp Arg
His Glu Arg Asp
His Arg Asp Glu
His Arg Glu Asp
His Val Asp Trp
His Val Trp Asp
His Trp Asp Val
His Trp Val Asp
Ile Phe Asn Tyr
Ile Phe Tyr Asn
Ile Asn Phe Tyr
Ile Asn Tyr Phe
Ile Tyr Phe Asn
Ile Tyr Asn Phe
Lys Asp Phe Phe
Lys Asp Met Tyr
Lys Asp Tyr Met
Lys Phe Asp Phe
Lys Phe Phe Asp
Lys Phe Met Met
Lys Met Asp Tyr
Lys Met Phe Met
Lys Met Met Phe
Lys Met Tyr Asp
Lys Tyr Asp Met
Lys Tyr Met Asp
Leu Phe Asn Tyr
Leu Phe Tyr Asn
Leu Asn Phe Tyr
Leu Asn Tyr Phe
Leu Tyr Phe Asn
Leu Tyr Asn Phe
Met Cys Phe Arg
Met Cys Arg Phe
Met Asp Lys Tyr
Met Asp Gln Tyr
Met Asp Tyr Lys
Met Asp Tyr Gln
Met Glu Asn Tyr
Met Glu Tyr Asn
Met Phe Cys Arg
Met Phe Lys Met
Met Phe Met Lys
Met Phe Met Gln
C24H37N5O6S2 (555.2185142000001)
Met Phe Gln Met
C24H37N5O6S2 (555.2185142000001)
Met Phe Arg Cys
Met Gly Trp Tyr
C27H33N5O6S (555.2151438000001)
Met Gly Tyr Trp
C27H33N5O6S (555.2151438000001)
Met Lys Asp Tyr
Met Lys Phe Met
Met Lys Met Phe
Met Lys Tyr Asp
Met Met Phe Lys
Met Met Phe Gln
C24H37N5O6S2 (555.2185142000001)
Met Met Lys Phe
Met Met Gln Phe
C24H37N5O6S2 (555.2185142000001)
Met Asn Glu Tyr
Met Asn Tyr Glu
Met Gln Asp Tyr
Met Gln Phe Met
C24H37N5O6S2 (555.2185142000001)
Met Gln Met Phe
C24H37N5O6S2 (555.2185142000001)
Met Gln Tyr Asp
Met Arg Cys Phe
Met Arg Phe Cys
Met Arg Ser Tyr
Met Arg Tyr Ser
Met Ser Arg Tyr
Met Ser Tyr Arg
Met Trp Gly Tyr
C27H33N5O6S (555.2151438000001)
Met Trp Tyr Gly
C27H33N5O6S (555.2151438000001)
Met Tyr Asp Lys
Met Tyr Asp Gln
Met Tyr Glu Asn
Met Tyr Gly Trp
C27H33N5O6S (555.2151438000001)
Met Tyr Lys Asp
Met Tyr Asn Glu
Met Tyr Gln Asp
Met Tyr Arg Ser
Met Tyr Ser Arg
Met Tyr Trp Gly
C27H33N5O6S (555.2151438000001)
Asn Glu Phe Phe
Asn Glu Met Tyr
Asn Glu Tyr Met
Asn Phe Glu Phe
Asn Phe Phe Glu
Asn Phe Ile Tyr
Asn Phe Leu Tyr
Asn Phe Tyr Ile
Asn Phe Tyr Leu
Asn Ile Phe Tyr
Asn Ile Tyr Phe
Asn Leu Phe Tyr
Asn Leu Tyr Phe
Asn Met Glu Tyr
Asn Met Tyr Glu
Asn Pro Tyr Tyr
Asn Tyr Glu Met
Asn Tyr Phe Ile
Asn Tyr Phe Leu
Asn Tyr Ile Phe
Asn Tyr Leu Phe
Asn Tyr Met Glu
Asn Tyr Pro Tyr
Asn Tyr Tyr Pro
Pro Asn Tyr Tyr
Pro Tyr Asn Tyr
Pro Tyr Tyr Asn
Gln Asp Phe Phe
Gln Asp Met Tyr
Gln Asp Tyr Met
Gln Phe Asp Phe
Gln Phe Phe Asp
Gln Phe Met Met
C24H37N5O6S2 (555.2185142000001)
Gln Phe Val Tyr
Gln Phe Tyr Val
Gln Met Asp Tyr
Gln Met Phe Met
C24H37N5O6S2 (555.2185142000001)
Gln Met Met Phe
C24H37N5O6S2 (555.2185142000001)
Gln Met Tyr Asp
Gln Val Phe Tyr
Gln Val Tyr Phe
Gln Tyr Asp Met
Gln Tyr Phe Val
Gln Tyr Met Asp
Gln Tyr Val Phe
Arg Cys Asp Tyr
C22H33N7O8S (555.2111218000001)
Arg Cys Phe Met
Arg Cys Met Phe
Arg Cys Tyr Asp
C22H33N7O8S (555.2111218000001)
Arg Asp Cys Tyr
C22H33N7O8S (555.2111218000001)
Arg Asp Glu His
Arg Asp His Glu
Arg Asp Tyr Cys
C22H33N7O8S (555.2111218000001)
Arg Glu Asp His
Arg Glu His Asp
Arg Phe Cys Met
Arg Phe Met Cys
Arg His Asp Glu
Arg His Glu Asp
Arg Met Cys Phe
Arg Met Phe Cys
Arg Met Ser Tyr
Arg Met Tyr Ser
Arg Ser Met Tyr
Arg Ser Tyr Met
Arg Tyr Cys Asp
C22H33N7O8S (555.2111218000001)
Arg Tyr Asp Cys
C22H33N7O8S (555.2111218000001)
Arg Tyr Met Ser
Arg Tyr Ser Met
Ser Met Arg Tyr
Ser Met Tyr Arg
Ser Arg Met Tyr
Ser Arg Tyr Met
Ser Thr Trp Tyr
Ser Thr Tyr Trp
Ser Trp Thr Tyr
Ser Trp Tyr Thr
Ser Tyr Met Arg
Ser Tyr Arg Met
Ser Tyr Thr Trp
Ser Tyr Trp Thr
Thr Cys Phe Trp
C27H33N5O6S (555.2151438000001)
Thr Cys Trp Phe
C27H33N5O6S (555.2151438000001)
Thr Phe Cys Trp
C27H33N5O6S (555.2151438000001)
Thr Phe Trp Cys
C27H33N5O6S (555.2151438000001)
Thr Ser Trp Tyr
Thr Ser Tyr Trp
Thr Trp Cys Phe
C27H33N5O6S (555.2151438000001)
Thr Trp Phe Cys
C27H33N5O6S (555.2151438000001)
Thr Trp Ser Tyr
Thr Trp Tyr Ser
Thr Tyr Ser Trp
Thr Tyr Trp Ser
Val Asp His Trp
Val Asp Trp His
Val His Asp Trp
Val His Trp Asp
Val Trp Asp His
Val Trp His Asp
Trp Cys Phe Thr
C27H33N5O6S (555.2151438000001)
Trp Cys Thr Phe
C27H33N5O6S (555.2151438000001)
Trp Asp His Val
Trp Asp Val His
Trp Phe Cys Thr
C27H33N5O6S (555.2151438000001)
Trp Phe Phe Gly
C31H33N5O5 (555.2481568000001)
Trp Phe Gly Phe
C31H33N5O5 (555.2481568000001)
Trp Phe Thr Cys
C27H33N5O6S (555.2151438000001)
Trp Gly Phe Phe
C31H33N5O5 (555.2481568000001)
Trp Gly Met Tyr
C27H33N5O6S (555.2151438000001)
Trp Gly Tyr Met
C27H33N5O6S (555.2151438000001)
Trp His Asp Val
Trp His Val Asp
Trp Met Gly Tyr
C27H33N5O6S (555.2151438000001)
Trp Met Tyr Gly
C27H33N5O6S (555.2151438000001)
Trp Ser Thr Tyr
Trp Ser Tyr Thr
Trp Thr Cys Phe
C27H33N5O6S (555.2151438000001)
Trp Thr Phe Cys
C27H33N5O6S (555.2151438000001)
Trp Thr Ser Tyr
Trp Thr Tyr Ser
Trp Val Asp His
Trp Val His Asp
Trp Tyr Gly Met
C27H33N5O6S (555.2151438000001)
Trp Tyr Met Gly
C27H33N5O6S (555.2151438000001)
Trp Tyr Ser Thr
Trp Tyr Thr Ser
Tyr Cys Asp Arg
C22H33N7O8S (555.2111218000001)
Tyr Cys Arg Asp
C22H33N7O8S (555.2111218000001)
Tyr Asp Cys Arg
C22H33N7O8S (555.2111218000001)
Tyr Asp Lys Met
Tyr Asp Met Lys
Tyr Asp Met Gln
Tyr Asp Gln Met
Tyr Asp Arg Cys
C22H33N7O8S (555.2111218000001)
Tyr Glu Met Asn
Tyr Glu Asn Met
Tyr Gly Met Trp
C27H33N5O6S (555.2151438000001)
Tyr Gly Trp Met
C27H33N5O6S (555.2151438000001)
Tyr Lys Asp Met
Tyr Lys Met Asp
Tyr Met Asp Lys
Tyr Met Asp Gln
Tyr Met Glu Asn
Tyr Met Gly Trp
C27H33N5O6S (555.2151438000001)
Tyr Met Lys Asp
Tyr Met Asn Glu
Tyr Met Gln Asp
Tyr Met Arg Ser
Tyr Met Ser Arg
Tyr Met Trp Gly
C27H33N5O6S (555.2151438000001)
Tyr Asn Glu Met
Tyr Asn Met Glu
Tyr Asn Pro Tyr
Tyr Asn Tyr Pro
Tyr Pro Asn Tyr
Tyr Pro Tyr Asn
Tyr Gln Asp Met
Tyr Gln Met Asp
Tyr Arg Cys Asp
C22H33N7O8S (555.2111218000001)
Tyr Arg Asp Cys
C22H33N7O8S (555.2111218000001)
Tyr Arg Met Ser
Tyr Arg Ser Met
Tyr Ser Met Arg
Tyr Ser Arg Met
Tyr Ser Thr Trp
Tyr Ser Trp Thr
Tyr Thr Ser Trp
Tyr Thr Trp Ser
Tyr Trp Gly Met
C27H33N5O6S (555.2151438000001)
Tyr Trp Met Gly
C27H33N5O6S (555.2151438000001)
Tyr Trp Ser Thr
Tyr Trp Thr Ser
Tyr Tyr Asn Pro
Tyr Tyr Pro Asn
Adomeglivant
C32H36F3NO4 (555.2596292000001)
C78276 - Agent Affecting Digestive System or Metabolism > C29711 - Anti-diabetic Agent
(T-4)-Difluoro[6-(2,4,6-trimethylphenyl)-N-[6-(2,4,6-trimethylphenyl)-2(1H)-quinolinylidene]-2-quinolinaminato]boron
Serlopitant
D018377 - Neurotransmitter Agents > D064729 - Neurokinin-1 Receptor Antagonists C78272 - Agent Affecting Nervous System > C267 - Antiemetic Agent
Rucaparib Camsylate
C29H34FN3O5S (555.2203086000001)
C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C62554 - Poly (ADP-Ribose) Polymerase Inhibitor C471 - Enzyme Inhibitor
propyl 3-O-(2-acetamido-2-deoxy-beta-D-glucopyranosyl)-2-O-(alpha-L-rhamnopyranosyl)-alpha-L-rhamnopyranoside
N-(Ethylsulfonyl)tryptophyl-N~1~-{4-[amino(imino)methyl]benzyl}glutamamide
4-[2-Acetylamino-2-(1-biphenyl-4-ylmethyl-2-oxo-azepan-3-ylcarbamoyl)-ethyl]-2-formyl-benzoic acid
C32H33N3O6 (555.2369238000001)
Rociletinib
C27H28F3N7O3 (555.2205614000001)
L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents > L01E - Protein kinase inhibitors > L01EB - Epidermal growth factor receptor (egfr) tyrosine kinase inhibitors C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C163952 - EGFR-targeting Agent C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor
(7,7-Dimethyl-2-oxo-1-bicyclo[2.2.1]heptanyl)methanesulfonic acid;6-fluoro-2-[4-(methylaminomethyl)phenyl]-3,10-diazatricyclo[6.4.1.04,13]trideca-1,4,6,8(13)-tetraen-9-one
C29H34FN3O5S (555.2203086000001)
(1R,2R,4S)-2-ethyl-2,5,7-trihydroxy-6,11-dioxo-4-{[2,3,6-trideoxy-3-(dimethylazaniumyl)-alpha-L-lyxo-hexopyranosyl]oxy}-1,2,3,4,6,11-hexahydrotetracene-1-carboxylate
(2R)-3-hydroxy-2-{[6-O-(6-O-octanoyl-alpha-D-glucopyranosyl)-alpha-D-glucopyranosyl]oxy}propanoate
[(2S,3R,4R,5R)-2-[(1S,2S,3R,4S,6R)-4-amino-3-[[(2S,3R)-3-amino-6-(aminomethyl)-3,4-dihydro-2H-pyran-2-yl]oxy]-6-(ethylamino)-2-hydroxycyclohexyl]oxy-5-hydroxy-5-methyl-4-(methylamino)oxan-3-yl] dihydrogen phosphate
(2S)-2-amino-5-[[(2R)-1-(carboxymethylamino)-3-[[(1S,2R,4R,7Z,11S)-4,8-dimethyl-13-oxo-3,14-dioxatricyclo[9.3.0.02,4]tetradec-7-en-12-yl]methylsulfanyl]-1-oxopropan-2-yl]amino]-5-oxopentanoic acid
C25H37N3O9S (555.2250392000001)
N-[[(8S,9S)-6-[(2S)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,13,14-tetrazabicyclo[10.2.1]pentadeca-12(15),13-dien-9-yl]methyl]-N-methyl-4-phenylbenzenesulfonamide
N-[[(8R,9S)-6-[(2S)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,14,15-tetrazabicyclo[10.3.0]pentadeca-12,14-dien-9-yl]methyl]-N-methyl-4-phenylbenzenesulfonamide
N-[[(8S,9S)-6-[(2R)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,13,14-tetrazabicyclo[10.2.1]pentadeca-12(15),13-dien-9-yl]methyl]-N-methyl-4-phenylbenzenesulfonamide
N-[[(8R,9R)-6-[(2S)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,14,15-tetrazabicyclo[10.3.0]pentadeca-12,14-dien-9-yl]methyl]-N-methyl-4-phenylbenzenesulfonamide
2-O-[6-O-Octanoyl-alpha-D-glucopyranosyl-(1->6)-alpha-D-glucopyranosyl]-D-glycerate
3-(4-fluorophenyl)-1-[[(4S,5R)-2-[(2S)-1-hydroxypropan-2-yl]-4-methyl-8-(2-methylphenyl)-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-1-methylurea
C29H34FN3O5S (555.2203086000001)
3-(4-fluorophenyl)-1-[[(4S,5S)-2-[(2R)-1-hydroxypropan-2-yl]-4-methyl-8-(2-methylphenyl)-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-1-methylurea
C29H34FN3O5S (555.2203086000001)
1-(3,5-dimethyl-1,2-oxazol-4-yl)-3-[(4S,7R,8R)-8-methoxy-4,7,10-trimethyl-11-oxo-5-(3,3,3-trifluoropropyl)-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]urea
3-(4-fluorophenyl)-1-[[(4R,5R)-2-[(2S)-1-hydroxypropan-2-yl]-4-methyl-8-(2-methylphenyl)-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-1-methylurea
C29H34FN3O5S (555.2203086000001)
3-(4-fluorophenyl)-1-[[(4S,5R)-2-[(2R)-1-hydroxypropan-2-yl]-4-methyl-8-(2-methylphenyl)-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-1-methylurea
C29H34FN3O5S (555.2203086000001)
3-(4-fluorophenyl)-1-[[(4R,5S)-2-[(2S)-1-hydroxypropan-2-yl]-4-methyl-8-(2-methylphenyl)-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-1-methylurea
C29H34FN3O5S (555.2203086000001)
3-(4-fluorophenyl)-1-[[(4R,5R)-2-[(2R)-1-hydroxypropan-2-yl]-4-methyl-8-(2-methylphenyl)-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-1-methylurea
C29H34FN3O5S (555.2203086000001)
3-(4-fluorophenyl)-1-[[(4S,5S)-2-[(2S)-1-hydroxypropan-2-yl]-4-methyl-8-(2-methylphenyl)-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-1-methylurea
C29H34FN3O5S (555.2203086000001)
3-(4-fluorophenyl)-1-[[(4R,5S)-2-[(2R)-1-hydroxypropan-2-yl]-4-methyl-8-(2-methylphenyl)-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-1-methylurea
C29H34FN3O5S (555.2203086000001)
1-(3,5-dimethyl-4-isoxazolyl)-3-[(4S,7S,8S)-8-methoxy-4,7,10-trimethyl-11-oxo-5-(3,3,3-trifluoropropyl)-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]urea
(3R)-2-[(R)-tert-butylsulfinyl]-3-(2-hydroxyethyl)-N-(pyridin-4-ylmethyl)-4-(3-pyridin-4-ylphenyl)-1,3-dihydropyrrolo[3,4-c]pyridine-6-carboxamide
C31H33N5O3S (555.2303988000001)
N-[[(4R,5R)-8-[2-(1-hydroxycyclopentyl)ethynyl]-2-[(2S)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methyl-2-pyridin-4-ylacetamide
C29H37N3O6S (555.2402942000001)
N-[[(4S,5S)-8-[2-(1-hydroxycyclopentyl)ethynyl]-2-[(2S)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methyl-2-pyridin-4-ylacetamide
C29H37N3O6S (555.2402942000001)
N-[[(4S,5R)-8-[2-(1-hydroxycyclopentyl)ethynyl]-2-[(2R)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methyl-2-pyridin-4-ylacetamide
C29H37N3O6S (555.2402942000001)
N-[[(4R,5S)-8-[2-(1-hydroxycyclopentyl)ethynyl]-2-[(2R)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methyl-2-pyridin-4-ylacetamide
C29H37N3O6S (555.2402942000001)
N-[[(4S,5R)-8-[2-(1-hydroxycyclopentyl)ethynyl]-2-[(2S)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methyl-2-pyridin-4-ylacetamide
C29H37N3O6S (555.2402942000001)
N-[[(4S,5S)-8-[2-(1-hydroxycyclopentyl)ethynyl]-2-[(2R)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methyl-2-pyridin-4-ylacetamide
C29H37N3O6S (555.2402942000001)
N-[[(4R,5R)-8-[2-(1-hydroxycyclopentyl)ethynyl]-2-[(2R)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methyl-2-pyridin-4-ylacetamide
C29H37N3O6S (555.2402942000001)
N-[[(4R,5S)-8-[2-(1-hydroxycyclopentyl)ethynyl]-2-[(2S)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methyl-2-pyridin-4-ylacetamide
C29H37N3O6S (555.2402942000001)
1-[[(4S,5S)-2-[(2S)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-8-[(E)-prop-1-enyl]-4,5-dihydro-3H-6,1lambda6,2-benzoxathiazocin-5-yl]methyl]-1-methyl-3-[4-(trifluoromethyl)phenyl]urea
1-(3,5-dimethyl-4-isoxazolyl)-3-[(4S,7R,8S)-8-methoxy-4,7,10-trimethyl-11-oxo-5-(3,3,3-trifluoropropyl)-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]urea
1-(3,5-dimethyl-4-isoxazolyl)-3-[(4R,7S,8R)-8-methoxy-4,7,10-trimethyl-11-oxo-5-(3,3,3-trifluoropropyl)-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]urea
1-(3,5-dimethyl-4-isoxazolyl)-3-[(4R,7R,8R)-8-methoxy-4,7,10-trimethyl-11-oxo-5-(3,3,3-trifluoropropyl)-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]urea
1-(3,5-dimethyl-4-isoxazolyl)-3-[(4R,7S,8S)-8-methoxy-4,7,10-trimethyl-11-oxo-5-(3,3,3-trifluoropropyl)-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]urea
1-(3,5-dimethyl-4-isoxazolyl)-3-[(4R,7R,8S)-8-methoxy-4,7,10-trimethyl-11-oxo-5-(3,3,3-trifluoropropyl)-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]urea
1-(3,5-dimethyl-4-isoxazolyl)-3-[(4S,7S,8R)-8-methoxy-4,7,10-trimethyl-11-oxo-5-(3,3,3-trifluoropropyl)-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]urea
(3S)-2-[(S)-tert-butylsulfinyl]-3-(2-hydroxyethyl)-N-(pyridin-4-ylmethyl)-4-(3-pyridin-4-ylphenyl)-1,3-dihydropyrrolo[3,4-c]pyridine-6-carboxamide
C31H33N5O3S (555.2303988000001)
2-O-demethyl-beta-anthrosyl-(1->3)-alpha-L-rhamnosyl-(1->3)-alpha-L-rhamnose
15-demethylaclacinomycin T zwitterion
A zwitterion obtained by transfer of a proton from the carboxy to the tertiary amino group of 15-demethylaclacinomycin T.
Tiapamil
C26H37NO8S2 (555.1960482000001)
C78274 - Agent Affecting Cardiovascular System > C270 - Antihypertensive Agent > C333 - Calcium Channel Blocker D002317 - Cardiovascular Agents > D002121 - Calcium Channel Blockers D000077264 - Calcium-Regulating Hormones and Agents D049990 - Membrane Transport Modulators C93038 - Cation Channel Blocker
3-vinylbacteriochlorophyllide d(1-)
A cyclic tetrapyrrole anion that is the conjugate base of 3-vinylbacteriochlorophyllide d, obtained by deprotonation of the carboxy group; major species at pH 7.3.
(rel)-AR234960
(rel)-AR234960 is an active relative configuration of AR234960. AR234960, a non-peptide MAS (a G protein-coupled receptor) agonist, increases both mRNA and protein levels of CTGF via ERK1/2 signaling in HEK293-MAS cells and adult human cardiac fibroblasts[1].
methyl 4-{[4-(dimethylamino)-5-hydroxy-6-methyloxan-2-yl]oxy}-2,5,7-trihydroxy-2-methyl-6,11-dioxo-3,4-dihydro-1h-tetracene-1-carboxylate
(1'r,2r,2'r,3'r,5's,8'r,9'r,10'r)-2',10'-bis(acetyloxy)-5'-hydroxy-8',12',15',15'-tetramethyl-13'-oxospiro[oxirane-2,4'-tricyclo[9.3.1.0³,⁸]pentadecan]-11'-en-9'-yl pyridine-3-carboxylate
(1r,3r,4as,5r,6s,6as,10ar,10br)-1,5-bis(acetyloxy)-4a,6a,7,10b-tetramethyl-5'-oxo-2,5,6,9,10,10a-hexahydro-1h-spiro[naphtho[2,1-b]pyran-3,3'-oxolan]-6-yl pyridine-3-carboxylate
(3r)-n-[(2s,4e)-6-amino-1-oxohex-4-en-2-yl]-3-cyano-3-{[4-(4-{[1-hydroxy-2-(n'-hydroxycarbamimidamido)ethylidene]amino}-1h-pyrrole-2-amido)-1h-pyrrol-2-yl]formamido}propanimidic acid
{6-[5-(5-{[4-(acetyloxy)-1-hydroxypent-2-en-1-ylidene]amino}-3,6-dimethyloxan-2-yl)-3-methylpenta-1,3-dien-1-yl]-4-(chloromethyl)-4-hydroxyoxan-2-yl}acetic acid
C28H42ClNO8 (555.2598802000001)
2-oxo-n-{[(1r,2s,10r,13r,14s)-14,16,19-trihydroxy-7,18-dimethoxy-6,17,21-trimethyl-5,8-dioxo-11,21-diazapentacyclo[11.7.1.0²,¹¹.0⁴,⁹.0¹⁵,²⁰]henicosa-4(9),6,15,17,19-pentaen-10-yl]methyl}propanamide
C28H33N3O9 (555.2216688000001)
methyl (1r,2s,4r)-4-{[(2s,4s,5r,6s)-4-(dimethylamino)-5-hydroxy-6-methyloxan-2-yl]oxy}-2,5,7-trihydroxy-2-methyl-6,11-dioxo-3,4-dihydro-1h-tetracene-1-carboxylate
1,5-bis(acetyloxy)-4a,6a,7,10b-tetramethyl-5'-oxo-2,5,6,9,10,10a-hexahydro-1h-spiro[naphtho[2,1-b]pyran-3,3'-oxolan]-6-yl pyridine-3-carboxylate
(22ar,23s,24r)-14,23,25-trihydroxy-24-methoxy-3,22a-dimethyl-12-phenyl-11h,12h,23h,24h-cyclopenta[v]1-oxa-12-azacyclotetracosan-1-one
n-[(4e)-6-amino-1-oxohex-4-en-2-yl]-3-cyano-3-{[4-(4-{[1-hydroxy-2-(n'-hydroxycarbamimidamido)ethylidene]amino}-1h-pyrrole-2-amido)-1h-pyrrol-2-yl]formamido}propanimidic acid
(2r)-n-[4-(acetyloxy)-5-[6-(dimethylamino)purin-9-yl]-2-(hydroxymethyl)oxolan-3-yl]-2-[(1-hydroxyethylidene)amino]-3-(4-methoxyphenyl)propanimidic acid
(22ar,23s)-1,14,23-trihydroxy-24-methoxy-3,22a-dimethyl-12-phenyl-11h,12h,23h,24h-cyclopenta[v]1-oxa-12-azacyclotetracosan-25-one
2',10'-bis(acetyloxy)-5'-hydroxy-8',12',15',15'-tetramethyl-13'-oxospiro[oxirane-2,4'-tricyclo[9.3.1.0³,⁸]pentadecan]-11'-en-9'-yl pyridine-3-carboxylate
[(2s,4s,6s)-6-[(1e,3e)-5-[(2s,3s,5r,6r)-5-{[(2z,4s)-4-(acetyloxy)-1-hydroxypent-2-en-1-ylidene]amino}-3,6-dimethyloxan-2-yl]-3-methylpenta-1,3-dien-1-yl]-4-(chloromethyl)-4-hydroxyoxan-2-yl]acetic acid
C28H42ClNO8 (555.2598802000001)